Table 1.
Distributions of selected baseline variables (N = 150).
| Baseline Variable | Percentage with Characteristic if Categorical | Mean ± SE if Continuous |
|---|---|---|
| Recipient age (years) | 46.9 ± 1.2 (N = 150) | |
| (Median = 48.0, range: 14–78) | ||
| Recipient gender | ||
| Female | 33.3% (50/150) | |
| Male | 66.7% (100/150) | |
| Recipient race/ethnicity | ||
| Black (non-Hispanic) | 20.7% (31/150) | |
| Hispanic | 37.3% (56/150) | |
| White (non-Hispanic) a | 42.0% (63/150) | |
| Recipient BMI (kg/m2) | 25.6 ± 0.4 (N = 150) | |
| (Median = 25.0, range: 16.0–44.0) | ||
| Recipient pretransplant diabetes mellitus | ||
| No | 82.7% (124/150) | |
| Yes | 17.3% (26/150) | |
| Recipient pretransplant history of cardiovascular disease | ||
| No | 81.3% (122/150) | |
| Yes | 18.7% (28/150) | |
| Preemptive transplant | ||
| No | 88.0% (132/150) | |
| Yes | 12.0% (18/150) | |
| Pretransplant time on dialysis (months) b | 29.1 ± 2.5 (N = 150) | |
| (Median = 20.7, range: 0–173.0) | ||
| Donor age (years) | 37.7 ± 1.2 (N = 150) | |
| (Median = 37.5, range: 11–66) | ||
| Donor type | ||
| LD | 19.3% (29/150) | |
| DD | 80.7% (121/150) | |
| CIT (h) among DD recipients | 32.2 ± 0.7 (N = 121) | |
| (Median = 32, range: 17–59) | ||
| DCD status | ||
| No | 96.0% (144/150) | |
| Yes | 4.0% (6/150) | |
| ECD status | ||
| No | 90.0% (135/150) | |
| Yes | 10.0% (15/150) | |
| PRA >5% | ||
| No | 95.3% (143/150) | |
| Yes | 4.7% (7/150) | |
| Total no. of HLA Mismatches | 3.6 ± 0.1 (N = 150) | |
| (Median = 4, Range: 0–6) |
Abbreviations: CIT, cold ischemia time; DCD, donation after cardiac death; DD, deceased donor; ECD, expanded criteria donor; HLA, human leukocyte antigen; LD, living donor; PRA, panel reactive antibodies. a Included among the White (non-Hispanic) subgroup were Southern Asian (N = 4), Middle Eastern (N = 2), and Native American Indian (N = 1) patients. b A value of 0.0 was used for preemptive transplant recipients.